Clostridioides difficile Infection

Docket Number: FDA-2022-D-1261 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of New Drugs The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled “Clostridioides...

Drug Promotion

HOST: Mary KremznerPHARMACIST #1: Beth CarrPHARMACIST #2:  Jaewon HongMARY: The Food and Drug Administration reviews advertising and promotional labels for prescription drugs to make sure the content isn’t false or misleading.  What materials are regulated? How can...

Communicating Benefit and Risk Information

Host: Capitan Mary KremznerPharmacist: LCDR Beth CarrCAPT Kremzner: Every medication approved by the FDA has benefits as well as risks. It’s important that patients hear both and have a clear understanding so they can make informed decisions with their health care...